Found 4 matching trials
A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
PHASE3The purpose of this study is to determine if there is an improvement in pro...
Location
Multiple Locations
A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple Myeloma
PHASE1The purpose of this study is to assess the safety and the tolerability of s...
Location
Multiple Locations
A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma
PHASE2The purpose of Part 1 of the study is to determine the safety of the combin...
Location
Multiple Locations
Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM)
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
University of Texas MD Anderson Cancer Center